Article Text

Download PDFPDF
Randomised double blind placebo controlled trial of inhaled fluticasone propionate in infants with chronic lung disease
  1. M W Beresford1,
  2. R Primhak2,
  3. N V Subhedar1,
  4. N J Shaw1
  1. 1Royal Liverpool Children's NHS Trust, Alder Hey, UK
  2. 2Sheffield Children's Hospital NHS Trust, UK
  1. Correspondence to:
    Dr N J Shaw, Neonatal Unit, Liverpool Women's Hospital, Liverpool L8 7SS, UK;{at}


In a double blind randomised controlled trial, 30 infants with chronic lung disease received fluticasone propionate or placebo for one year. There were no significant differences between treatment groups in the incidence of any day or night time symptoms or any other outcome measures.

  • fluticasone
  • chronic lung disease
  • double blind
  • randomised

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


Linked Articles

  • Fantoms
    Ben Stenson